Publikācijas » Search Results » 2016

 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962
Rezultātu skaits lapā  
Scopus datu bāzē indeksētās publikācijas
71Ozols K.; Cīrule D.; Novosjolova I.; Stepanovs D.; Liepinsh E.; Bizdēna Ē.; *Turks M. Development of N6-methyl-2-(1,2,3-triazol-1-yl)-2′-deoxyadenosine as a novel fluorophore and its application in nucleotide synthesis. Tetrahedron Lett. 2016, 57(10), 1174-1178.      

72*Markovic D.; Tchawou W.A.; Novosjolova I.; Laclef S.; Stepanovs D.; Turks M.; Vogel P. Synthesis and Applications of Silyl 2-Methylprop-2-ene-1-sulfinates in Preparative Silylation and GC-Derivatization Reactions of Polyols and Carbohydrates. Chem. Eur. J. 2016, 22(12), 4196-4205.      

73Isaksson R.; Kumpiņa I.; Larhed M.; *Wannberg J. Rapid and straightforward transesterification of sulfonyl carbamates. Tetrahedron Lett. 2016, 57(13), 1476-1478.      

74Sjakste T.; Paramonova N.; Ošiņa K.; Dokane K.; Sokolovska J.; Sjakste N. Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals. Mol. Genet. Genomics 2016, 291(2), 891-903.      

75Mierina I.; *Stepanovs D.; Kuginyte J.; Janichev A.; Jure M. Crystal structure of 3-(4-hydroxyphenyl)-2-[(E)-2- phenylethenyl]quinazolin-4(3H)-one. Acta Crystallographica Section E: Crystallographic Communications 2016, 72, 522-525.      

76*Sjakste T.; Paramonova N.; Ošiņa K.; Dokane K.; Sokolovska J.; Sjakste N. Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in latvians and with expression level of number of UPS‑related and T1DM‑susceptible genes in HapMap individuals. Mol. Genet. Genomics 2016, 291(2), 891-903.      

77*Terentjeva S.; Muceniece D.; Petushkova J.; Lūsis V. Synthesis of novel 3-substituted benzamides related to imatinib. J. Chem. Res. 2016, 40(4), 224-227.      

78*Dambrova M.; Latkovskis G.; Kūka J.; Strele I.; Konrāde I.; Grinberga S.; Hartmane D.; Pugovičs O.; Erglis A.; Liepinsh E. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels. Exp. Clin. Endocrinol. Diabetes 2016, 124(4), 251-256.      

79Sarceviča I.; Grante I.; Belyakov S.; Rekis T.; Bērziņš K.; Actins A.; *Orola L. Solvates of Dasatinib: Diversity and Isostructurality. J. Pharm. Sci. 2016, 105(4), 1489-1495.      

80*Smits R.; Turovska B.; Belyakov S.; Plotniece A.; Duburs G. Synthesis of 5-carboxy-6-methyl-3,4-dihydro-2(1H)-pyridone derivatives and their electrochemical oxidation to 2-pyridones. Chem. Phys. Lett. 2016, 649, 84-87.      

Rezultātu skaits lapā